Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-08-04
2009-11-24
Jiang, Shaojia Anna (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S057000, C514S059000, C514S060000
Reexamination Certificate
active
07622575
ABSTRACT:
The present invention is directed to methods of using glucan compositions, comprising water insoluble microparticulate glucans, in the treatment of connective tissue injuries. The water insoluble microparticulate glucans used in the compositions comprise branched β-(1,3)(1,6) glucan. The glucan compositions used in the present invention are essentially free of unbranched β-(1,3)(1,6) glucan and non-glucan components.
REFERENCES:
patent: 4739046 (1988-04-01), Di Luzio
patent: 4810646 (1989-03-01), Jamas et al.
patent: 4833131 (1989-05-01), Williams et al.
patent: 4960697 (1990-10-01), Johal et al.
patent: 4973581 (1990-11-01), Matsuzaki et al.
patent: 4992540 (1991-02-01), Jamas et al.
patent: 5084386 (1992-01-01), Tusé et al.
patent: 5238925 (1993-08-01), Bentley
patent: 5278172 (1994-01-01), Hennessey
patent: 5397773 (1995-03-01), Donzis
patent: 6242594 (2001-06-01), Kelly
patent: B-62296/86 (1990-07-01), None
patent: B-64411/90 (1994-06-01), None
patent: 883444 (1980-11-01), None
patent: 0 682 877 (2003-04-01), None
patent: 55-076817 (1980-06-01), None
patent: 55-076818 (1980-06-01), None
patent: 55-078001 (1980-06-01), None
patent: 59-210901 (1984-11-01), None
patent: 61-291509 (1986-12-01), None
patent: 62-205008 (1987-09-01), None
patent: 63-017828 (1988-01-01), None
patent: WO 87/01037 (1987-02-01), None
patent: WO 90/12106 (1990-10-01), None
patent: WO 91/03495 (1991-03-01), None
patent: WO 94/04163 (1994-03-01), None
patent: WO 97/46208 (1997-12-01), None
Derwent Abstract Accession No. 52394 C/30, JP 55-076817 A, Jun. 10, 1980, 1 page.
Derwent Abstract Accession No. 52395 C/30, JP 55-076818 A, Jun. 10, 1980, 1 page.
Derwent Abstract Accession No. 52560 C/30, JP 55-078001 A, Jun. 12, 1980, 1 page.
Derwent Abstract Accession No. 85-015010/03, JP 59-210901 A, Nov. 29, 1984, 2 pages.
Derwent Abstract Accession No. 86381 C/49, B04, BE 883 444 A, Nov. 24, 1980, 1 page.
Derwent Abstract Accession No. 87-033998/05, JP 61-291509 A, Dec. 22, 1986, 1 page.
Derwent Abstract Accession No. 87-294398/42 D16, D17, JP 62-205008 A, Sep. 9, 1987, 1 page.
Duckova, K. et al., “Some results of preclinical and clinical evaluation of topical preparations containing glucan,”Proc. 1stWorld Meeting APGI/APV, Budapest, Hungary, pp. 729-730 (1995).
International Search Report for WIPO Appl. No. PCT/AU96/00138, mailed on May 15, 1996,5 pages.
International Preliminary Examination Report for WIPO Appl. No. PCT/AU96/00138, completed on Mar. 12, 1997, 6 pages.
Supplementary European Search Report for EP Appl. No. EP 96 90 4672, dated Nov. 29, 2000, 3 pages.
Search Report under Section 17 for GB Appl. No. GB 9823767.0, date of search Mar. 3, 1999, 1 page.
Office Action mailed Jun. 23, 1998 for U.S. Patent No. 6,242,594.
Amendments filed Dec. 23, 1998, for U.S. Patent No. 6,242,594.
Office Action mailed Mar. 31, 1999, for U.S. Patent No. 6,242,594.
Amendment filed Sep. 30, 1999, for U.S. Patent No. 6,242,594.
Final Office Action mailed Dec. 23, 1999, for U.S. Patent No. 6,242,594.
Amendment After Final filed Jun. 21, 2000, for U.S. Patent No. 6,242,594.
Office Action mailed Jun. 19, 2001, for U.S. Appl. No. 09/643,940.
Amendment filed Dec. 19, 2001, for U.S. Appl. No. 09/643,940.
Office Action mailed Mar. 11, 2002, for U.S. Appl. No. 09/643,940.
Amendment filed Aug. 8, 2002, for U.S. Appl. No. 09/643,940.
Office Action mailed Oct. 22, 2002, for U.S. Appl. No. 09/643,940.
Office Action mailed Dec. 8, 2004, for U.S. Appl. No. 10/421,659.
Amendment and Response filed May 6, 2005, for U.S. Appl. No. 10/421,659.
Final Office Action mailed Jul. 26, 2005, for U.S. Appl. No. 10/421,659.
Amendment After Final filed Aug. 31, 2005, for U.S. Appl. No. 10/421,659.
Office Action mailed Feb. 6, 2006, for U.S. Appl. No. 10/421,659.
Response filed May 8, 2006, for U.S. Appl. No. 10/421,659.
Advisory Action mailed Jul. 20, 2006, for U.S. Appl. No. 10/421,659.
Muller et al., Lipid Content of Microparticulate (1→3)-β-D-Glucan Isolated fromSaccharomyces cerevisiae, Microbios79, 1994, pp. 253-261.
Jiang Shaojia Anna
Novogen Research Pty. Ltd.
White E.
LandOfFree
Therapeutic uses of glucan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic uses of glucan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic uses of glucan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4137903